Serum GFAP And Neurofilament Light As Biomarkers Of Disease Activity And Disability In NMOSD
…10.1212/WNL.0000000000008160. doi: 10.1212/WNL.0000000000008160. Abstract Objective: To test the hypothesis that serum levels of glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL), which are an intermediate astrocyte and neuron filaments, respectively, are clinically useful biomarkers of disease activity and disability in…
read more